Diagnostic and therapeutic advances in neuroendocrine tumours

被引:18
作者
Caplin, Martyn E. [1 ]
Ratnayake, Gowri M. [1 ]
机构
[1] Royal Free Hosp, ENETS Ctr Excellence, Neuroendocrine Tumour Unit, London, England
关键词
D O I
10.1038/s41574-020-00458-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroendocrine neoplasms are derived from the diffuse endocrine system and represent a spectrum of tumours with a diverse range of molecular abnormalities, functionality and anatomical locations. Here, some key advances in molecular diagnosis, functional imaging and therapeutic strategies that have been published in 2020 are discussed.
引用
收藏
页码:81 / 82
页数:2
相关论文
共 10 条
[1]   PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest [J].
Bodei, Lisa ;
Kidd, Mark S. ;
Singh, Aviral ;
van der Zwan, Wouter A. ;
Severi, Stefano ;
Drozdov, Ignat A. ;
Malczewska, Anna ;
Baum, Richard P. ;
Kwekkeboom, Dik J. ;
Paganelli, Giovanni ;
Krenning, Eric P. ;
Modlin, Irvin M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) :895-906
[2]   A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601) [J].
Capdevila, J. ;
Teule, A. ;
Lopez, C. ;
Garcia-Carbonero, R. ;
Benavent, M. ;
Custodio, A. ;
Cubillo, A. ;
Alonso, V. ;
Alonso Gordoa, T. ;
Carmona-Bayonas, A. ;
Crespo, G. ;
Blanco-Codesido, M. ;
Jimenez-Fonseca, P. ;
Viudez, A. ;
La Casta Munoa, A. ;
Sevilla, I. ;
Llanos, M. ;
Segura, A. ;
Hernando-Cubero, J. ;
Manzano, J. L. .
ANNALS OF ONCOLOGY, 2020, 31 :S770-S771
[3]  
Liu X, 2020, HELL J NUCL MED, V23, P188, DOI 10.1967/s002449912108
[4]   An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis [J].
Malczewska, Anna ;
Kidd, Mark ;
Matar, Somer ;
Kos-Kudla, Beata ;
Bodei, Lisa ;
Oberg, Kjell ;
Modlin, Irvin M. .
NEUROENDOCRINOLOGY, 2020, 110 (3-4) :198-216
[5]   Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study [J].
Mehnert, Janice M. ;
Bergsland, Emily ;
O'Neil, Bert H. ;
Santoro, Armando ;
Schellens, Jan H. M. ;
Cohen, Roger B. ;
Doi, Toshihiko ;
Ott, Patrick A. ;
Pishvaian, Michael J. ;
Puzanov, Igor ;
Aung, Kyaw L. ;
Hsu, Chiun ;
Le Tourneau, Christophe ;
Hollebecque, Antoine ;
Elez, Elena ;
Tamura, Kenji ;
Gould, Marlena ;
Yang, Ping ;
Stein, Karen ;
Piha-Paul, Sarina A. .
CANCER, 2020, 126 (13) :3021-3030
[6]   Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? [J].
Merola, Elettra ;
Rinke, Anja ;
Partelli, Stefano ;
Gress, Thomas M. ;
Andreasi, Valentina ;
Kollar, Attila ;
Perren, Aurel ;
Christ, Emanuel ;
Panzuto, Francesco ;
Pascher, Andreas ;
Jann, Henning ;
Arsenic, Ruza ;
Cremer, Birgit ;
Kaemmerer, Daniel ;
Kump, Patrizia ;
Lipp, Rainer W. ;
Agaimy, Abbas ;
Wiedenmann, Bertram ;
Falconi, Massimo ;
Pavel, Marianne E. .
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) :1348-1355
[7]   A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood [J].
Oberg, K. ;
Califano, A. ;
Strosberg, J. R. ;
Ma, S. ;
Pape, U. ;
Bodei, L. ;
Kaltsas, G. ;
Toumpanakis, C. ;
Goldenring, J. R. ;
Frilling, A. ;
Paulson, S. .
ANNALS OF ONCOLOGY, 2020, 31 (02) :202-212
[8]   A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors [J].
Patel, Sandip P. ;
Othus, Megan ;
Chae, Young Kwang ;
Giles, Francis J. ;
Hansel, Donna E. ;
Singh, Preet Paul ;
Fontaine, Annette ;
Shah, Manisha ;
Kasi, Anup ;
Al Baghdadi, Tareq ;
Matrana, Marc ;
Gatalica, Zoran ;
Korn, W. Michael ;
Hayward, Jourdain ;
McLeod, Christine ;
Chen, Helen X. ;
Sharon, Elad ;
Mayerson, Edward ;
Ryan, Christopher W. ;
Plets, Melissa ;
Blanke, Charles ;
Kurzrock, Razelle .
CLINICAL CANCER RESEARCH, 2020, 26 (10) :2290-2296
[9]   Efficacy of 177Lu Peptide Receptor Radionuclide Therapy for the Treatment of Neuroendocrine Tumors A Meta-analysis [J].
Saravana-Bawan, Bianka ;
Bajwa, Amandeep ;
Paterson, John ;
McEwan, Alexander J. B. ;
McMullen, Todd P. W. .
CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) :719-727
[10]   Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours [J].
Young, Kate ;
Lawlor, Rita T. ;
Ragulan, Chanthirika ;
Patil, Yatish ;
Mafficini, Andrea ;
Bersani, Samantha ;
Antonello, Davide ;
Mansfield, David ;
Cingarlini, Sara ;
Landoni, Luca ;
Pea, Antonio ;
Luchini, Claudio ;
Piredda, Liliana ;
Kannan, Nagarajan ;
Nyamundanda, Gift ;
Morganstein, Daniel ;
Chau, Ian ;
Wiedenmann, Bertram ;
Milella, Michele ;
Melcher, Alan ;
Cunningham, David ;
Starling, Naureen ;
Scarpa, Aldo ;
Sadanandam, Anguraj .
GUT, 2021, 70 (10) :1904-1913